Captrust Financial Advisors Bio Techne Corp Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Bio Techne Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 50,771 shares of TECH stock, worth $3.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,771

Previous 55,977 9.3%

Holding current value

$3.71 Million

Previous $4.01 Million 1.17%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $369,417 - $428,714	-5,206 Reduced 9.3%	50,771 $4.06 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $108,275 - $146,673	1,743 Added 3.21%	55,977 $4.01 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $730,992 - $854,080	-11,079 Reduced 16.96%	54,234 $3.82 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $93,297 - $138,136	1,766 Added 2.78%	65,313 $5.04 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $43,415 - $57,497	-643 Reduced 1.0%	63,547 $4.33 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $211,764 - $246,848	-2,871 Reduced 4.28%	64,190 $5.24 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $22,417 - $27,112	-313 Reduced 0.46%	67,061 $4.98 Million
Q4 2022 Feb 15, 2023	BUY	$80.67 - $352.29 $4.21 Million - $18.4 Million	52,167 Added 343.05%	67,374 $5.58 Million
Q3 2022 Nov 16, 2022	BUY	$282.54 - $391.85 $685,442 - $950,628	2,426 Added 18.98%	15,207 $4.32 Million
Q2 2022 Aug 23, 2022	SELL	$322.67 - $449.65 $653,084 - $910,091	-2,024 Reduced 13.67%	12,781 $4.43 Million
Q2 2022 Aug 16, 2022	BUY	$322.67 - $449.65 $871,854 - $1.21 Million	2,702 Added 22.33%	14,805 $5.13 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $353,142 - $486,814	998 Added 8.99%	12,103 $5.24 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $83,475 - $96,085	-183 Reduced 1.62%	11,105 $5.75 Million
Q3 2021 Nov 16, 2021	SELL	$444.87 - $538.88 $161,932 - $196,152	-364 Reduced 3.12%	11,288 $5.47 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $215,366 - $250,344	-556 Reduced 4.55%	11,652 $5.25 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $43,417 - $56,718	138 Added 1.14%	12,208 $4.66 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $42,219 - $55,039	171 Added 1.44%	12,070 $3.83 Million
Q3 2020 Nov 17, 2020	BUY	$232.22 - $282.96 $251,494 - $306,445	1,083 Added 10.01%	11,899 $2.96 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $65,085 - $98,125	-351 Reduced 3.14%	10,816 $2.88 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $27,560 - $37,878	171 Added 1.56%	11,167 $2.07 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $46,661 - $54,634	-246 Reduced 2.19%	10,996 $2.41 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $21,476 - $25,356	117 Added 1.05%	11,242 $2.2 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $943 - $1,077	-5 Reduced 0.04%	11,125 $2.32 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $7,621 - $11,224	56 Added 0.51%	11,130 $2.21 Million
Q4 2018 Feb 13, 2019	SELL	$132.75 - $203.8 $3,186 - $4,891	-24 Reduced 0.22%	11,074 $1.6 Million
Q3 2018 Nov 15, 2018	SELL	$147.44 - $204.11 $10,320 - $14,287	-70 Reduced 0.63%	11,098 $2.27 Million
Q2 2018 Aug 13, 2018	SELL	$144.9 - $165.58 $78,535 - $89,744	-542 Reduced 4.63%	11,168 $1.65 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $11,305 - $12,989	86 Added 0.74%	11,710 $1.7 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $75,610 - $84,084	624 Added 5.67%	11,624 $1.51 Million
Q3 2017 Feb 16, 2018	BUY	$113.59 - $123.78 $1.25 Million - $1.36 Million	11,000	11,000 $1.51 Million

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Bio Techne Corp Transaction History